Rigel Pharmaceuticals, Inc. (RIGL)

USD 17.07

(-7.48%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 117.22 Million 134.27 Million 167.32 Million 110.37 Million 147.56 Million 139.1 Million
Total Current Assets 99.26 Million 115.9 Million 154.46 Million 88.98 Million 119 Million 136.98 Million
Cash And Short Term Investments 56.93 Million 58.2 Million 124.96 Million 57.32 Million 98.07 Million 128.53 Million
Cash and Cash Equivalents 32.78 Million 24.45 Million 18.89 Million 30.37 Million 22.52 Million 76.32 Million
Short Term Investments 24.14 Million 33.74 Million 106.07 Million 26.95 Million 75.55 Million 52.21 Million
Net Receivables 30.55 Million 40.32 Million 15.47 Million 15.97 Million 10.11 Million 4.07 Million
Inventory 5.52 Million 9.11 Million 6.61 Million 1.63 Million 1.35 Million 894 Thousand
Other Current Assets 6.26 Million 8.25 Million 7.41 Million 14.04 Million 9.46 Million 3.47 Million
Total Non-Current Assets 17.95 Million 18.37 Million 12.86 Million 21.39 Million 28.56 Million 2.12 Million
Net PPE 1.02 Million 2.78 Million 11.88 Million 20.57 Million 27.86 Million 1.38 Million
Good Will And Intangible Assets 13.87 Million 14.94 Million - - - -
Good Will - - - - - -
Intangible Assets 13.87 Million 14.94 Million - - - -
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 3.05 Million 640 Thousand 974 Thousand 824 Thousand 696 Thousand 735 Thousand
Other Assets - - - - - -
Total Liabilities 145.86 Million 147.89 Million 136.95 Million 76.35 Million 93.75 Million 29.23 Million
Total Current Liabilities 53.26 Million 65.21 Million 63.55 Million 40.84 Million 58.21 Million 27.73 Million
Account Payables 7.14 Million 22.5 Million 3.79 Million 3.7 Million 4.15 Million 6.39 Million
Tax Payables - - - - - -
Short Term Debt 7.92 Million 1.13 Million 9.89 Million 8.62 Million 7.27 Million -
Deferred Revenue 17.03 Million 13.51 Million 2.59 Million 3.01 Million 25.28 Million 1.03 Million
Other Current Liabilities 21.16 Million 28.05 Million 47.27 Million 25.49 Million 21.5 Million 20.31 Million
Total Non Current Liabilities 92.6 Million 82.68 Million 73.4 Million 35.51 Million 35.54 Million 1.49 Million
Long-Term Debt 52.65 Million 40.42 Million 20.67 Million 30.46 Million 29.04 Million -
Deferred Revenue Non Current - - - - 1.4 Million 1.4 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 39.94 Million 42.26 Million 52.72 Million 5.04 Million 5.09 Million 90 Thousand
Other Liabilities - - - - - -
Total Equity -28.64 Million -13.61 Million 30.37 Million 34.02 Million 53.81 Million 109.87 Million
Stock Holders Equity -28.64 Million -13.61 Million 30.37 Million 34.02 Million 53.81 Million 109.87 Million
Common Stock 175 Thousand 174 Thousand 172 Thousand 169 Thousand 168 Thousand 167 Thousand
Retained Earnings -1.4 Billion -1.38 Billion -1.32 Billion -1.3 Billion -1.27 Billion -1.2 Billion
Accumulated other comprehensive income 8000.00 -153 Thousand -102 Thousand -4000.00 23 Thousand -24 Thousand
Common Stock Equity -28.64 Million -13.61 Million 30.37 Million 34.02 Million 53.81 Million 109.87 Million
Capital Lease Obligation 977 Thousand 2.1 Million 10.65 Million 19.27 Million 26.5 Million -
Total Investments 24.14 Million 33.74 Million 106.07 Million 26.95 Million 75.55 Million 52.21 Million
Total Debt 60.57 Million 41.55 Million 30.56 Million 39.08 Million 36.31 Million -
Net Debt 27.79 Million 17.09 Million 11.67 Million 8.71 Million 13.79 Million -76.32 Million

Balance Sheet Charts